Efficacy of platelets collected by semi-continuous flow centrifugation (Haemonetics Model 30). 1978

S J Slichter

The viability of both autologous and donor platelets collected by means of a semi-continuous flow centrifuge (Haemonetics Model 30) was measured. Radiochromium labelled pooled platelets harvested from six passes and reinfused into their normal donors showed recoveries and survivals of 58% +/- 8 and 9.6 d +/- 0.8 compared with normal values of 65% and 9.5 d +/- 0.6, respectively. When the viability in aplastic thrombocytopenic recipients of platelets collected from normal donors by the Haemonetics Model 30 was compared with that of platelets collected from the same donors by multiple bag plateletpheresis the results were very similar: recoveries of 82% +/- 18 and 80% +/- 25 and survivals of 3.9 d +/- 2.0 and 3.8 d +/- 1.3, respectively. The in vitro function of the collected platelets in response to aggregating agents was normal when measured within 60 min of collection at pH 7.4. The relationship between bleeding time and post-transfusion platelet count in aplastic, thrombocytopenic patients showed that in vivo function was maintained.

UI MeSH Term Description Entries
D010956 Plasmapheresis Procedure whereby plasma is separated and extracted from anticoagulated whole blood and the red cells retransfused to the donor. Plasmapheresis is also employed for therapeutic use. Double Filtration Plasmapheresis,Therapeutic Immunoadsorption,Therapeutic Plasma Adsorption,Therapeutic Plasmapheresis,Adsorption, Therapeutic Plasma,Adsorptions, Therapeutic Plasma,Double Filtration Plasmaphereses,Filtration Plasmapheresis, Double,Immunoadsorption, Therapeutic,Plasma Adsorption, Therapeutic,Plasmaphereses,Plasmapheresis, Double Filtration,Plasmapheresis, Therapeutic,Therapeutic Immunoadsorptions,Therapeutic Plasma Adsorptions,Therapeutic Plasmaphereses
D010974 Platelet Aggregation The attachment of PLATELETS to one another. This clumping together can be induced by a number of agents (e.g., THROMBIN; COLLAGEN) and is part of the mechanism leading to the formation of a THROMBUS. Aggregation, Platelet
D001777 Blood Coagulation The process of the interaction of BLOOD COAGULATION FACTORS that results in an insoluble FIBRIN clot. Blood Clotting,Coagulation, Blood,Blood Clottings,Clotting, Blood
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D002498 Centrifugation Process of using a rotating machine to generate centrifugal force to separate substances of different densities, remove moisture, or simulate gravitational effects. It employs a large motor-driven apparatus with a long arm, at the end of which human and animal subjects, biological specimens, or equipment can be revolved and rotated at various speeds to study gravitational effects. (From Websters, 10th ed; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013048 Specimen Handling Procedures for collecting, preserving, and transporting of specimens sufficiently stable to provide accurate and precise results suitable for clinical interpretation. Specimen Collection,Collection, Specimen,Collections, Specimen,Handling, Specimen,Handlings, Specimen,Specimen Collections,Specimen Handlings
D013921 Thrombocytopenia A subnormal level of BLOOD PLATELETS. Thrombopenia,Thrombocytopenias,Thrombopenias

Related Publications

S J Slichter
March 1980, [Rinsho ketsueki] The Japanese journal of clinical hematology,
S J Slichter
April 1991, Australian journal of biotechnology,
S J Slichter
January 1977, Minnesota medicine,
Copied contents to your clipboard!